Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.55+0.63 (+4.53%)
Close on Nov 18, 2026Market cap $1.05BP/E –Yield –
Omeros net income
Net income is the profit left for shareholders after every expense, interest and tax.
Omeros's net income for the twelve months ending Jun 30, 2026 was $124.83M. For fiscal 2025 it was -$3.35M. The highest annual figure on record is $194.24M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.35M | – |
| FY2024 | Dec 31, 2024 | -$156.82M | – |
| FY2023 | Dec 31, 2023 | -$117.81M | -348.5% |
| FY2022 | Dec 31, 2022 | $47.42M | -75.6% |
| FY2021 | Dec 31, 2021 | $194.24M | – |
| FY2020 | Dec 31, 2020 | -$138.06M | – |
| FY2019 | Dec 31, 2019 | -$84.49M | – |
| FY2018 | Dec 31, 2018 | -$126.76M | – |
| FY2017 | Dec 31, 2017 | -$53.48M | – |
| FY2016 | Dec 31, 2016 | -$66.75M | – |
| FY2015 | Dec 31, 2015 | -$75.10M | – |
| FY2014 | Dec 31, 2014 | -$73.67M | – |
| FY2013 | Dec 31, 2013 | -$39.80M | – |
| FY2012 | Dec 31, 2012 | -$38.44M | – |
| FY2011 | Dec 31, 2011 | -$28.55M | – |
| FY2010 | Dec 31, 2010 | -$29.25M | – |
| FY2009 | Dec 31, 2009 | -$21.09M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.23M | – |
| Q1 FY2026 | Mar 31, 2026 | $56.06M | – |
| Q4 FY2025 | Dec 31, 2025 | $86.45M | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$25.42M | – |
| Q1 FY2025 | Mar 31, 2025 | -$33.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$31.36M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$56.04M | – |
| Q1 FY2024 | Mar 31, 2024 | -$37.18M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.07M | -107.0% |
| Q3 FY2023 | Sep 30, 2023 | -$37.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$37.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$33.70M | – |
| Q4 FY2022 | Dec 31, 2022 | $128.73M | -54.1% |
| Q3 FY2022 | Sep 30, 2022 | -$17.46M | – |
| Q2 FY2022 | Jun 30, 2022 | -$30.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.01M | – |
| Q4 FY2021 | Dec 31, 2021 | $280.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$35.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$37.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$38.46M | – |
| Q2 FY2020 | Jun 30, 2020 | -$33.29M | – |
| Q1 FY2020 | Mar 31, 2020 | -$29.03M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.23M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.46M | – |
| Q2 FY2019 | Jun 30, 2019 | -$14.45M | – |
| Q1 FY2019 | Mar 31, 2019 | -$24.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$23.53M | – |
| Q3 FY2018 | Sep 30, 2018 | -$39.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$33.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$30.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$16.55M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.48M | – |
| Q2 FY2017 | Jun 30, 2017 | -$14.36M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$19.63M | – |
| Q3 FY2016 | Sep 30, 2016 | -$13.96M | – |
| Q2 FY2016 | Jun 30, 2016 | -$12.61M | – |
See a number that looks wrong?